Estrogen receptors and the aging brain

S Maioli, K Leander, P Nilsson… - Essays in Biochemistry, 2021 - portlandpress.com
The female sex hormone estrogen has been ascribed potent neuroprotective properties. It
signals by binding and activating estrogen receptors that, depending on receptor subtype …

Sex differences in cognitive impairment and Alzheimer's disease

R Li, M Singh - Frontiers in neuroendocrinology, 2014 - Elsevier
Studies have shown differences in specific cognitive ability domains and risk of Alzheimer's
disease between the men and women at later age. However it is important to know that sex …

Multivariate meta-analyses of mitochondrial complex I and IV in major depressive disorder, bipolar disorder, schizophrenia, Alzheimer disease, and Parkinson disease

L Holper, D Ben-Shachar, JJ Mann - Neuropsychopharmacology, 2019 - nature.com
Abstract Complex I (NADH dehydrogenase, NDU) and complex IV (cytochrome-c-oxidase,
COX) of the mitochondrial electron transport chain have been implicated in the …

Estrogen signaling in Alzheimer's disease: molecular insights and therapeutic targets for Alzheimer's dementia

MS Uddin, MM Rahman, M Jakaria, MS Rahman… - Molecular …, 2020 - Springer
Estrogens play a crucial physiological function in the brain; however, debates exist
concerning the role of estrogens in Alzheimer's disease (AD). Women during pre-, peri-, or …

[HTML][HTML] Is Alzheimer's disease a systemic disease?

JK Morris, RA Honea, ED Vidoni, RH Swerdlow… - … et Biophysica Acta (BBA …, 2014 - Elsevier
Although Alzheimer's disease (AD) is the most common neurodegenerative disease, the
etiology of AD is not well understood. In some cases, genetic factors explain AD risk, but a …

From menopause to neurodegeneration—molecular basis and potential therapy

YJ Cheng, CH Lin, HY Lane - International journal of molecular sciences, 2021 - mdpi.com
The impacts of menopause on neurodegenerative diseases, especially the changes in
steroid hormones, have been well described in cell models, animal models, and humans …

Targeting nuclear receptors in neurodegeneration and neuroinflammation

S Willems, D Zaienne, D Merk - Journal of medicinal chemistry, 2021 - ACS Publications
Nuclear receptors, also known as ligand-activated transcription factors, regulate gene
expression upon ligand signals and present as attractive therapeutic targets especially in …

Central and peripheral metabolic defects contribute to the pathogenesis of Alzheimer's disease: targeting mitochondria for diagnosis and prevention

Y Peng, P Gao, L Shi, L Chen, J Liu… - Antioxidants & redox …, 2020 - liebertpub.com
Significance: Epidemiological studies indicate that metabolic disorders are associated with
an increased risk for Alzheimer's disease (AD). Metabolic remodeling occurs in the central …

Intermittent fasting protects against the deterioration of cognitive function, energy metabolism and dyslipidemia in Alzheimer's disease-induced estrogen deficient rats

BK Shin, S Kang, DS Kim… - Experimental biology and …, 2018 - journals.sagepub.com
Intermittent fasting may be an effective intervention to protect against age-related metabolic
disturbances, although it is still controversial. Here, we investigated the effect of intermittent …

Brain sex matters: estrogen in cognition and Alzheimer's disease

R Li, J Cui, Y Shen - Molecular and cellular endocrinology, 2014 - Elsevier
Estrogens are the primary female sex hormones and play important roles in both
reproductive and non-reproductive systems. Estrogens can be synthesized in non …